Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UC-MSC therapy in diabetic nephropathy
NCT07396155Phase 2Recruiting
- Sponsor
- Prodia Stem Cell Indonesia
- Start
- Jul 2026
- Primary completion
- Jul 2027
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of human umbilical cord mesenchymal stem cells in diabetic nephropathy (DN), sponsored by Prodia Stem Cell Indonesia. Started Jul 2026; status: recruiting.
02
Drugs
human umbilical cord mesenchymal stem cells
03
Conditions
diabetic nephropathy (DN)
Beyond the preview
Go deeper on NCT07396155.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07396155.